Literature DB >> 21816210

Comparative pharmacokinetics of dehydroevodiamine and coptisine in rat plasma after oral administration of single herbs and Zuojinwan prescription.

Rui Yan1, Yin Wang, Wenjin Shen, Youping Liu, Xin Di.   

Abstract

Zuojinwan, which consists of Rhizoma coptidis-Evodia rutaecarpa powder (6:1,g/g), is a traditional Chinese medicine (TCM) prescription, clinically used for the treatment of gastro-intestinal disorders. This study compared the pharmacokinetics of dehydroevodiamine and coptisine, the main active ingredients in Zuojinwan, in rats administrated with whole prescription or single herbs. Multiple blood concentration peaks were observed in the mean plasma-concentration curves. The pharmacokinetic parameters were quite different between single herbs and Zuojinwan prescription. Moreover, the mean plasma concentration of dehydroevodiamine increased and the one of coptisine decreased after combining, which was in accord with the clinical principle of TCM.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816210     DOI: 10.1016/j.fitote.2011.07.012

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  5 in total

1.  Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice.

Authors:  Shun-Ting Chou; Chien-Yun Hsiang; Hsin-Yi Lo; Hui-Fen Huang; Ming-Tsung Lai; Ching-Liang Hsieh; Su-Yin Chiang; Tin-Yun Ho
Journal:  BMC Complement Altern Med       Date:  2017-02-20       Impact factor: 3.659

2.  Pharmacokinetic-Pharmacodynamic Modeling for Coptisine Challenge of Inflammation in LPS-Stimulated Rats.

Authors:  Yingfan Hu; Li Wang; Li Xiang; Jiasi Wu; Wen'ge Huang; Chensi Xu; Xianli Meng; Ping Wang
Journal:  Sci Rep       Date:  2019-02-05       Impact factor: 4.379

3.  Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.

Authors:  Siqi Huang; Zheyu Zhang; Wenqun Li; Fanhua Kong; Pengji Yi; Jianhua Huang; Dan Mao; Weijun Peng; Sifang Zhang
Journal:  Drug Des Devel Ther       Date:  2020-07-14       Impact factor: 4.162

4.  Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis.

Authors:  Guohua Yu; Wubin Wang; Xu Wang; Meng Xu; Lili Zhang; Lei Ding; Rui Guo; Yuanyuan Shi
Journal:  BMC Complement Altern Med       Date:  2018-11-01       Impact factor: 3.659

Review 5.  Processing and Polyherbal Formulation of Tetradium ruticarpum (A. Juss.) Hartley: Phytochemistry, Pharmacokinetics, and Toxicity.

Authors:  Qi-Yuan Shan; Xia-Nan Sang; Hui Hui; Qi-Yang Shou; Hui-Ying Fu; Min Hao; Kao-Hua Liu; Qiao-Yan Zhang; Gang Cao; Lu-Ping Qin
Journal:  Front Pharmacol       Date:  2020-03-06       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.